Accessibility: Skip TopNav
CCAB partners with ImmunoBiochem Corporation for advancement of novel breast cancer therapeutic
Anton Neschadim, CEO, ImmunoBiochem Corporation (left) and Robert Verhagen, CEO, CCAB
Format
JPEG
Source
Centre for the Commercialization of Antibodies and Biologics
Downloads
Original
Large
Medium
Small